心塞通口服液对大鼠心肌梗死后心律失常影响的实验研究  

An experimental study on the effect of Xinsai Tong oral to the rats arrhythmia after myocardial infarction

作　　者：宫爱民[1] 郭茂松[2] 

机构地区：[1]海南医学院中医学院,海南海口571101 [2]黑龙江省中医研究院,黑龙江哈尔滨150036

出　　处：《中医临床研究》2011年第14期1-2,共2页Clinical Journal Of Chinese Medicine

基　　金：海南省自然基金资助项目(项目编号:811208);海南省自然基金资助项目(项目编号:811210)

摘　　要：预防心肌梗死后心律失常发生是现代医学面临的最大挑战之一。心塞通口服液是郭文勤教授结合四十余年临床经验,结合现代研究成果,成功地研制出已应用于临床多年的有效方剂。本研究从心脏电生理作为切入点,证实心塞通口服液能显著降低心梗后心律失常的发生,其作用机制与改善AMI后心室晚电位、降低QTd有关,本研究可作为心肌梗死后心律失常有效药筛选提供参考。Arrhythmia prevention after myocardial infarction is modem medicine＇s greatest challenges. Xinsai Tong oral is Professor GUO Wen-qin through more than four decades clinical experience, combined with modem research, has successfully developed many years of effective clinical prescription. In this study, as an entry point from cardiac electrophysiology, confirmed through Xinsai Tong oral can significantly reduce the incidence of arrhythmias after myocardial infarction and improve its mechanism of ventricular late potentials after AMI, reduced QTd on this study can be used for arrhythmia after myocardial infarction disorders and provided an effective reference.

关 键 词：心塞通口服液 心肌梗死 心律失常 心室晚电位 QT离散度 

分 类 号：R541.7[医药卫生—心血管疾病]